Get startedLog in
    Picture of Basilea Pharmaceutica AG Allschwil logo

    BSLN — Basilea Pharmaceutica AG Allschwil Balance Sheet

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual balance sheet for Basilea Pharmaceutica AG Allschwil, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:—————
    Source:ARSARSARSARSARS
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Cash
    Cash and Equivalents
    Short Term Investments
    Cash and Short Term Investments16214984.759.9121
    Net Total Accounts Receivable
    Net Total Receivables32.464.461.758.158.2
    Total Inventory
    Total Other Current Assets
    Total Current Assets224241175152221
    Gross Property, Plant And Equipment
    Accumulated Depreciation
    Net Property, Plant And Equipment5.282.9221.620.619
    Net Intangible Assets
    Long Term Investments
    Long Term Notes Receivable
    Other Long Term Assets
    Total Assets230247221173258
    Accounts Payable
    Accrued Expenses
    Notes Payable / Short Term Debt
    Current Portion of Long Term Debt / Capital Leases
    Total Other Current Liabilities
    Total Current Liabilities50.217474.847.645.6
    Long Term Debt
    Total Long Term Debt
    Total Debt
    Total Other Liabilities
    Total Funded Status
    Total Liabilities332306242183177
    Common Stock
    Additional Paid In Capital
    Retained Earnings (Accumulated Deficit)
    Treasury Stock
    Other Equity
    Total Equity-102-58.6-20.7-1081
    Total Liabilities & Shareholders' Equity230247221173258
    Total Common Shares Outstanding